Maribavir for Suspension(Takeda Pharma)

马立巴韦干混悬剂（武田医药）

Report date: 2025/11/04 13:24:11

Base Information

Drug NameMaribavir for Suspension(Takeda Pharma)
Drug Alias NameBenzimidavir马立巴韦Maribavirum马立巴韦干混悬剂（2.2类改良型）
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA synthesis inhibitorsUL97 kinase inhibitors
TargetsUL97 kinase
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTakeda Pharmaceuticals USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA Inc
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG